Form D · Biotechnology

Metagenomi Technologies, LLC

Emeryville, CA · CIK 0001785279

Offering snapshot reported Jan 11, 2023 · SEC filing

Reported sold
$95.8M
Offering amount: $100M
Investors reported
25
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Dec 20, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 11, 2023Initial$95,790,739No comparison25SEC filing
Feb 7, 2022Initial$175,374,794No comparison29SEC filing
Mar 29, 2021Initial$9,999,995No comparison2SEC filing
Nov 25, 2020Initial$37,544,506No comparison11SEC filing
Aug 16, 2019Initial$26,373,182No comparison16SEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-470286
Series B-1 Preferred units

Source: Form D, filed Jan 11, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Sebastian Bernales Director
Willard Dere Director
Juergen Eckhardt Director
Andrew Farquharson Director
Jak Knowles Director
Andrew Levin Director
Santhosh Palani Director
Santosh Palani Director
Risa Stack Director
Brian C. Thomas Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1545 Park Avenue
Emeryville, CA, 94608